Editorial: Shouldn't everyone have an implantable cardioverter- defibrillator?

Circulation

Volumn 120, Issue 22, 2009, Pages 2166-2167

  Passman, Rod ^a   Kadish, Alan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Arrhythmia; Death, sudden; Defibrillation; Editorials

Indexed keywords

AMIODARONE;

CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEFIBRILLATOR; EDITORIAL; ELECTRIC SHOCK; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SUDDEN DEATH; HEART ARRHYTHMIA; NOTE;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS;

EID: 73449106789     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.907303     Document Type: Editorial

References (11)

1. Moore W. The Knife Man. London, UK: Bantam Books; 2005:188.
2. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303: 322-324.
3. Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the Sudden Cardiac Death in Heart Failure Trial. Circulation. 2009;120:2170-2176.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
5. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol. 2004;43:1459-1465.
6. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH. Prophylactic defibrillator implantation in patients with nonis-chemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158.
7. Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozfarrian D, Linker DT, Maggioni A, Anand I, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH. Use of Seattle Heart Failure Model to identify benefit vs harm from a primary prevention ICD. Heart Rhythm. 2008;5:S78.
8. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproduc-ibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64: 1227-1234.
9. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008;51:288-296.
10. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: structure, function, and time-dependence of risk. Circulation. 1992; 85(suppl):I-2-I-10.
11. Kadish AH, Bello D, Finn JP, Bonow RO, Schaechter A, Subacius H, Albert C, Daubert JP, Fonseca CG, Goldberger JJ. Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) Trial. J Cardiovasc Electrophysiol. 2009;20: 982-987.